• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次发生静脉血栓形成后的癌症发病率和死亡率:瑞典北部的一项队列研究。

Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden.

作者信息

Hägg Lovisa, Ehrs Felicia, Lind Marcus, Johansson Magdalena

机构信息

Department of Public Health and Clinical Medicine, Skellefteå Research Unit, Umeå University, Umeå, Sweden.

出版信息

Thromb J. 2024 Aug 21;22(1):77. doi: 10.1186/s12959-024-00646-z.

DOI:10.1186/s12959-024-00646-z
PMID:39169417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11337770/
Abstract

BACKGROUND

Venous thromboembolism (VTE) has a high mortality rate and can be the first manifestation of cancer. We investigated the incidence of cancer after first-ever VTE and the association between VTE and all-cause mortality.

METHODS

A Swedish cohort study that included 105,997 participants without previous cancer who underwent a health examination from 1985-2014 was conducted. Manually validated first-ever VTE events, incident cancer according to the Swedish cancer registry, and mortality were registered. Participants were followed until September 5, 2014.

RESULTS

The mean age at inclusion was 46.2 years, and 50.3% of participants were female. We identified 1303 persons in the cohort with a VTE and no previous cancer. Among these, 179 (13.7%) were diagnosed with cancer after the VTE event, resulting in a cancer incidence of 26.4 (95% CI 22.8-30.6) cases per 1000 person-years. The incidence was highest during the first 6 months after the VTE. In the study population, VTE was associated with an increased risk of cancer (HR 1.95 [95% CI 1.67-2.29] in a multivariable model). VTE was also associated with an increased risk of death (HR 6.30 [95% CI 5.82-6.81]) in a multivariable model). There was an interaction between sex and VTE in relation to both risk of cancer and mortality, with a stronger association in women.

CONCLUSIONS

The incidence of cancer is high after first-ever VTE, especially close to the VTE event. VTE seems to be a stronger risk marker in women than in men for both cancer and death.

摘要

背景

静脉血栓栓塞症(VTE)死亡率高,且可能是癌症的首发表现。我们调查了首次发生VTE后癌症的发病率以及VTE与全因死亡率之间的关联。

方法

开展了一项瑞典队列研究,纳入105997名既往无癌症且在1985年至2014年期间接受健康检查的参与者。人工验证首次发生的VTE事件、根据瑞典癌症登记处记录的新发癌症以及死亡率。对参与者进行随访直至2014年9月5日。

结果

纳入时的平均年龄为46.2岁,50.3%的参与者为女性。我们在队列中识别出1303名发生VTE且既往无癌症的人。其中,179人(13.7%)在VTE事件后被诊断出患有癌症,癌症发病率为每1千人年26.4例(95%置信区间22.8 - 30.6)。发病率在VTE后的前6个月最高。在研究人群中,VTE与癌症风险增加相关(多变量模型中风险比为1.95 [95%置信区间1.67 - 2.29])。多变量模型中,VTE还与死亡风险增加相关(风险比为6.30 [95%置信区间5.82 - 6.81])。在癌症风险和死亡率方面,性别与VTE之间存在相互作用,女性中的关联更强。

结论

首次发生VTE后癌症发病率高,尤其是在接近VTE事件时。对于癌症和死亡而言,VTE似乎在女性中比在男性中是更强的风险标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9678/11337770/6fb65958cbc6/12959_2024_646_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9678/11337770/783d9cc9341a/12959_2024_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9678/11337770/6fb65958cbc6/12959_2024_646_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9678/11337770/783d9cc9341a/12959_2024_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9678/11337770/6fb65958cbc6/12959_2024_646_Fig2_HTML.jpg

相似文献

1
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden.首次发生静脉血栓形成后的癌症发病率和死亡率:瑞典北部的一项队列研究。
Thromb J. 2024 Aug 21;22(1):77. doi: 10.1186/s12959-024-00646-z.
2
Incidence of Recurrent Venous Thromboembolism in a Population-Based Cohort.基于人群的队列研究中静脉血栓栓塞复发的发生率。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241293337. doi: 10.1177/10760296241293337.
3
Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study.瑞典北部静脉血栓栓塞症(VEINS)的发生率:一项基于人群的研究。
Thromb J. 2014 Mar 4;12(1):6. doi: 10.1186/1477-9560-12-6.
4
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.基于人群的与各种口服避孕药相关的静脉血栓栓塞风险研究。
Lancet. 1997 Jan 11;349(9045):83-8. doi: 10.1016/s0140-6736(96)07496-x.
5
Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.前列腺癌男性与普通人群男性的静脉血栓栓塞风险比较:瑞典全国基于人群的队列研究。
BMJ Open. 2022 May 23;12(5):e055485. doi: 10.1136/bmjopen-2021-055485.
6
Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index.静脉血栓栓塞症短期死亡率与静脉血栓栓塞症家族史和 Charlson 合并症指数的关系。
Thromb Haemost. 2019 Jan;119(1):48-55. doi: 10.1055/s-0038-1676347. Epub 2018 Dec 31.
7
Incidence and risk factors of venous thromboembolism in men and women.男性和女性静脉血栓栓塞症的发生率和危险因素。
Thromb Res. 2022 Jun;214:82-86. doi: 10.1016/j.thromres.2022.04.014. Epub 2022 Apr 26.
8
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.活动性癌症患者首次及复发性静脉血栓栓塞的流行病学。一项基于人群的队列研究。
Thromb Haemost. 2017 Jan 5;117(1):57-65. doi: 10.1160/TH15-08-0686. Epub 2016 Oct 6.
9
Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.空腹血糖、口服葡萄糖耐量试验与首次静脉血栓栓塞风险。来自 VEINS 队列研究的报告。
Thromb Res. 2018 May;165:86-94. doi: 10.1016/j.thromres.2018.03.015. Epub 2018 Mar 27.
10
Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study.静脉血栓栓塞的家族史与静脉血栓栓塞后的死亡率:一项基于瑞典人群的队列研究。
J Thromb Thrombolysis. 2017 May;43(4):469-475. doi: 10.1007/s11239-016-1464-y.

引用本文的文献

1
Correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden.通信:瑞典北部首次发生静脉血栓形成后的癌症发病率和死亡率
Thromb J. 2024 Nov 4;22(1):96. doi: 10.1186/s12959-024-00667-8.

本文引用的文献

1
Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study.癌症相关静脉血栓形成后的生存情况:斯堪的纳维亚血栓和癌症研究。
Blood Adv. 2023 Aug 8;7(15):4072-4079. doi: 10.1182/bloodadvances.2022009577.
2
Sex differences in long-term outcomes of patients with deep vein thrombosis.深静脉血栓形成患者的长期结局存在性别差异。
Vascular. 2023 Oct;31(5):994-1002. doi: 10.1177/17085381221097746. Epub 2022 May 3.
3
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
4
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.癌症患者与非癌症患者的动脉和静脉血栓栓塞风险比较——一项全国性分析。
Eur Heart J. 2021 Jun 14;42(23):2299-2307. doi: 10.1093/eurheartj/ehab171.
5
Cancer-associated thrombosis: the when, how and why.癌症相关血栓形成:何时、如何以及为何。
Eur Respir Rev. 2019 Mar 27;28(151). doi: 10.1183/16000617.0119-2018. Print 2019 Mar 31.
6
Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.未诱发的静脉血栓栓塞症类型与癌症位置之间的关系:一项个体患者数据荟萃分析。
Thromb Res. 2019 Apr;176:79-84. doi: 10.1016/j.thromres.2019.02.011. Epub 2019 Feb 13.
7
Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries.瑞典患者登记系统中肺栓塞和深静脉血栓形成诊断的阳性预测值及误诊情况
Clin Epidemiol. 2018 Sep 17;10:1215-1221. doi: 10.2147/CLEP.S177058. eCollection 2018.
8
Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.空腹血糖、口服葡萄糖耐量试验与首次静脉血栓栓塞风险。来自 VEINS 队列研究的报告。
Thromb Res. 2018 May;165:86-94. doi: 10.1016/j.thromres.2018.03.015. Epub 2018 Mar 27.
9
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH.静脉血栓栓塞症患者的隐匿性癌症筛查:国际血栓与止血学会科学与标准化委员会的指南
J Thromb Haemost. 2017 Oct;15(10):2076-2079. doi: 10.1111/jth.13791. Epub 2017 Aug 29.
10
Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis.静脉血栓栓塞症结局的性别差异:基于全国住院患者样本(NIS)的分析。
Vasc Med. 2017 Apr;22(2):121-127. doi: 10.1177/1358863X17693103. Epub 2017 Mar 20.